Erring on the side of action: Time for HIV programmes to implement isoniazid preventive therapy

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 8, 2009, Pages 925-926

  Granich, Reuben ^a   Getahun, Haileyesus ^a   Reid, Alasdair ^b   Raviglione, Mario ^a   De Cock, Kevin M ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

COMMUNITY; EDITORIAL; EVIDENCE BASED MEDICINE; FAMILY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERVENTION STUDY; LUNG TUBERCULOSIS; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; RISK REDUCTION; TUBERCULIN TEST; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; COMORBIDITY; HIV INFECTIONS; HUMANS; ISONIAZID; PUBLIC HEALTH; TUBERCULOSIS;

EID: 69149092655     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/ TB/2009.411. Geneva, Switzerland: WHO, 2009. www.who. int/tb/publications/global-report/2009/pdf/full-report.pdf Accessed June 2009.
2. World Health Organization. Towards universal access: scaling up priority HIV/AIDS intervention in the health sector. WHO report. Geneva, Switzerland: WHO, 2008. www.who.int/hiv/ pub/towards-universal-access-report-2008.pdf Accessed June 2009.
3. UNAIDS. 2007 AIDS epidemic update. UNAIDS report 2007. Geneva, Switzerland: UNAIDS, 2007. www.unaids.org/en/ KnowledgeCentre/HIVData/EpiUpdate/ EpiUpdArchive/2007/ Accessed June 2009.
4. Woldehann S, Volmink J. Treatment of latent tuberculosis infection in HIV infected person. Cochrane Database Syst Rev 2004(1): CD000171.
5. Aït-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13: 927-935.
6. UNAIDS. Policy statement on preventive therapy against tuberculosis in people living wth HIV: report of a meeting held in Geneva 18-20 February 1998. WHO/TB/98.255; UNAIDS/ 98.34. Geneva, Switzerland: UNAIDS, 1998. whqlibdoc.who. int/HQ/1998/WHO-TB-98.255.pdf Accessed June 2009.
7. World Health Organization. Interim policy on collaborative TB/ HIV activities. WHO/HTM/TB/2004.330; WHO/HTM/HIV/ 2004.1. Geneva, Switzerland: WHO, 2004.
8. World Health Organization. WHO Three I's meeting: intensified case finding (IC), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Report of a Joint World Health Organization HIV/AIDS and TB Department Meeting, 2-4 April 2008, Geneva, Switzerland, www.who. int/hiv/pub/tb/3is-mreport/en/index.html Accessed June 2009.
9. World Health Organization. Essential prevention and care interventions for adults and adolescent living with HIV in resource-limited settings WHO/HTM/TB/2008 WHO/HTM/HIV/2008. Geneva, Switzerland: WHO, 2008. www.who.int/hiv/pub/ prev-care/OMS-EPP-AFF-en.pdf Accessed June 2009.
10. UNAIDS. Practical guidelines for intensifying HIV prevention -towards universal access. UNAIDS/07.07E/JC1274E 2007. Geneva, Switzerland: UNAIDS, 2007. http://data.unaids.org/ pub/Manual/2007/jc1274-towardsuniversalaccess-en.pdf Accessed June 2009.
11. Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet 2008; 372: 845-859.
12. Bunnell R, Ekwaru J P, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20: 85-92. (Pubitemid 41818118)
13. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064. (Pubitemid 34680968)
14. Lawn S D, Myer L, Edwards D, Bekker L G, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009; May 20 [epub ahead of print]. www.ncbi.nlm.nih. gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt= Citation&list-uids=19461502 Accessed June 2009.
15. Girardi E, Sabin C A, d'Arminio Monforte A, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005; 41: 1772-1782.
16. Golub J E, Saraceni V, Cavalcante S C, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21: 1441-1448. (Pubitemid 46988004)
17. Golub J E, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009; 23: 631-636.
18. UNAIDS. Joint Outcome Commitment framework. Geneva, Switzerland: UNAIDS, 2009. data.unaids.org/pub/BaseDocument/ 2009/JC1713-Joint-Action-en.pdf Accessed June 2009.